MS
SILK

Maven Securities’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Maven Securities’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,755
Closed -$600K – 432
2019
Q3 		$600K Buy
+18,755
New +$747K 0.19% 128

Other funds holding SILK

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Maven Securities's SILK Position: Q4 2019 in Review

Maven Securities sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2019, closing a stake of 18,755 shares — an estimated $600K sold.

Maven Securities first reported a position in SILK in Q3 2019 and held it in 1 quarter. The position peaked at $600K in Q3 2019. 130 funds tracked by Wall St. Rank hold SILK as of Q4 2019.

  • Maven Securities reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Maven Securities sold 18,755 Silk Road Medical, Inc. Common Stock shares in Q4 2019, an estimated $600K.
  • Maven Securities first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Maven Securities's Silk Road Medical, Inc. Common Stock position peaked at $600K in Q3 2019.
  • 130 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2019.

Based on Maven Securities's 13F filing for Q4 2019, filed 14 Feb 2020.